Research analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research note issued on Monday. The firm set a “hold” rating on the stock.
China Pharma Stock Up 3.0 %
Shares of CPHI opened at $0.26 on Monday. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17. The stock’s fifty day simple moving average is $0.29 and its 200 day simple moving average is $0.38. China Pharma has a twelve month low of $0.24 and a twelve month high of $2.05.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%. The company had revenue of $1.37 million during the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- How Investors Can Find the Best Cheap Dividend Stocks
- RXO Shares Surge Following New Acquisition Deal
- Where Do I Find 52-Week Highs and Lows?
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Find Undervalued Stocks
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
